Status:
COMPLETED
Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
Brigham and Women's Hospital
Beth Israel Deaconess Medical Center
Conditions:
Breast Cancer
Hodgkin's Disease
Eligibility:
FEMALE
20+ years
Brief Summary
The purpose of this study is to determine if the use of breast MRI in detecting breast malignancies in survivors of Hodgkin's disease is more successful than the traditional mammogram.
Detailed Description
* The screening breast MRI and mammography will be performed 6 months or longer after the last mammogram. For pre-menopausal women, the screening will be performed during the second week of the menstr...
Eligibility Criteria
Inclusion
- Female patients treated with radiation therapy to the chest area for Hodgkin's disease
- Age between 12 and 35 at initial treatment
- Eight years or longer after initial treatment
- Pre-approval from the participant's insurance company for the breast imaging studies
Exclusion
- Pregnant or lactating women
- Post Bilateral mastectomy
- Currently undergoing breast cancer therapy
- Known metastatic cancer
- Patients with contraindications for undergoing an MRI: cardiac pacemaker, known metallic objects in body e.g. metallic clips, bullets, shrapnel or buckshots.
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT00165412
Start Date
July 1 2005
End Date
May 1 2010
Last Update
May 2 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
2
Dana-Farber Cancer Center
Boston, Massachusetts, United States, 02115
3
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215